scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | M Oellerich | |
J M Potter | |||
P2860 | cites work | The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450 | Q34421122 |
Assessment of the (14C) aminopyrine breath test in liver disease | Q34473764 | ||
Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation | Q34498280 | ||
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients | Q34567114 | ||
Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites | Q37713715 | ||
Clinical Pharmacokinetics of Lignocaine | Q39725309 | ||
Quantitative Assessment of Deranged Hepatic Function: A Missed Opportunity? | Q40164732 | ||
Evidence for pre-hepatic metabolism of oral cyclosporine in children | Q42081648 | ||
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury | Q42574211 | ||
Selection criteria for liver transplant donors | Q43808170 | ||
Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. | Q51659415 | ||
Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. | Q51659423 | ||
Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver. | Q51667347 | ||
Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX) | Q51681773 | ||
Assessment of lidocaine metabolite formation as a quantitative liver function test in children. | Q51727203 | ||
Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. | Q51747037 | ||
Lignocaine metabolite formation as a measure of pre-transplant liver function. | Q51755557 | ||
Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. | Q55060683 | ||
P433 | issue | 3 | |
P921 | main subject | lidocaine | Q216935 |
P304 | page(s) | 211-224 | |
P577 | publication date | 1996-05-01 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | The use of lidocaine as a test of liver function in liver transplantation | |
P478 | volume | 2 |
Q46239194 | Assessment of liver function by the MEGX test in patients with schistosomiasis and cirrhosis |
Q42796815 | Evaluating human liver reserve function by measuring serum concentrations of phenacetin and its metabolites |
Q51495318 | Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans. |
Q26741225 | Predictive factors of short term outcome after liver transplantation: A review |
Q34109294 | The clinical importance of conventional and quantitative liver function tests in liver transplantation |
Q49100561 | The lidocaine monoethylglycinexylidide test of liver function |